What is Ceryx Medical?
Ceryx Medical is at the forefront of developing bioelectronics powered by unique, patent-protected chip technology designed to replicate Central Pattern Generators (CPGs) within the human body. These artificial CPGs are engineered to restore autonomic or rhythmical bodily processes, such as peristalsis, heart rate, and locomotion, which may be impaired due to disease or injury. The company's innovative approach aims to address critical unmet needs in medical rehabilitation and chronic condition management.
How much funding has Ceryx Medical raised?
Ceryx Medical has raised a total of $11.6M across 2 funding rounds:
Angel/Seed
$4.8M
Other Financing Round
$6.8M
Angel/Seed (2022): $4.8M with participation from BGF, Parkwalk Advisors, Development Bank of Wales, and Icehouse Ventures
Other Financing Round (2025): $6.8M led by BGF, Parkwalk Advisors, and Development Bank of Wales
Key Investors in Ceryx Medical
BGF
BGF is a prominent investor in UK small and mid-sized businesses, supporting companies across various stages of growth and sectors.
Parkwalk Advisors
Parkwalk Advisors specializes in investing in deeptech innovations from UK universities, providing crucial funding and expertise to university spinouts.
Development Bank of Wales
The Development Bank of Wales offers business finance solutions, including loans and equity, to support companies in Wales, particularly those in technology development.
What's next for Ceryx Medical?
The substantial enterprise-level backing positions Ceryx Medical for accelerated growth and market penetration. This capital infusion is expected to fuel further research and development, scale manufacturing capabilities, and expand clinical trials. The company's focus on CPG technology suggests a trajectory towards commercializing advanced therapeutic devices, potentially transforming patient care in neurology, cardiology, and rehabilitation medicine. Future strategic partnerships and regulatory approvals will be key milestones.
See full Ceryx Medical company page
